Matrix metalloproteinase-7 triggers the matricrine action of insulin-like growth factor-II via proteinase activity on insulin-like growth factor binding protein 2 in the extracellular matrix.
about
IGF-Binding Protein 2 - Oncogene or Tumor Suppressor?Insulin-like growth factor system in cancer: novel targeted therapiesChronic matrix metalloproteinase inhibition retards age-associated arterial proinflammation and increase in blood pressureExogenous administration of protease-resistant, non-matrix-binding IGFBP-2 inhibits tumour growth in a murine model of breast cancer.Insulin-like growth factor binding proteins: a structural perspective.Insulin-like growth factor-1, IGF binding protein-3, and the risk of esophageal cancer in a nested case-control study.Luteolin decreases IGF-II production and downregulates insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cellsInterleukin-2 is present in human blood vessels and released in biologically active form by heparanase.IGFBP-2 - taking the lead in growth, metabolism and cancerLaminin-111 stimulates proliferation of mouse embryonic stem cells through a reduction of gap junctional intercellular communication via RhoA-mediated Cx43 phosphorylation and dissociation of Cx43/ZO-1/drebrin complex.Functional evolution of IGF2:IGF2R domain 11 binding generates novel structural interactions and a specific IGF2 antagonistThe effect of forced expression of mutated K-RAS gene on gastrointestinal cancer cell lines and the IGF-1R targeting therapy.Insulin-like growth factor-related components and the risk of liver cancer in a nested case-control study.A candidate targeting molecule of insulin-like growth factor-I receptor for gastrointestinal cancers.Matrix metalloproteinase-1 facilitates MSC migration via cleavage of IGF-2/IGFBP2 complex.Insulin/IGF-driven cancer cell-stroma crosstalk as a novel therapeutic target in pancreatic cancer.Trichostatin A reverses the chemoresistance of lung cancer with high IGFBP2 expression through enhancing autophagy.Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer Patients.
P2860
Q27003443-98497950-D2A1-47CF-B59B-A80167523DB7Q28081603-52C15F42-4B8A-4122-A695-03755B9EB983Q28392730-59FDD268-55AA-4D19-AA29-AD3C8D7EC5C9Q30384833-35A1535C-2A32-4659-8611-6298E4147F52Q30417447-F4CBEBB0-AAF1-4366-99DC-DD238C543B52Q33719968-D85E6A4D-DD5C-42E0-81DE-E2074D2CB58DQ34136150-B33CB5AD-1968-4EEA-BA08-952F263ED636Q35181984-F6364240-3E81-4146-A3A3-8F8FBD278175Q35690628-2F827FA1-3890-4F01-A5E7-D483CE7D8919Q36093179-DF7E9185-9FC7-48D0-BD73-000623D09A69Q36930975-FECBABC2-3224-45F3-BB33-6E8E884E7017Q38764039-96F0B50B-73A6-4A0F-9298-9E48C0B98788Q40529321-B301C8CF-F90C-44B3-89BB-37F6D68D74D2Q42540944-35F92118-FFF2-422B-B0C4-74F9D36FB724Q49514696-14F725F2-CC5A-4221-B8CB-E117D06FB9CDQ50314975-DA5305B5-038A-4EAA-B287-3F9ED4BFB364Q54966612-57212E46-18C8-40FF-B757-63A0189CBFC3Q55518473-2C83CD34-6523-4193-A329-1A5730FAFB85
P2860
Matrix metalloproteinase-7 triggers the matricrine action of insulin-like growth factor-II via proteinase activity on insulin-like growth factor binding protein 2 in the extracellular matrix.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Matrix metalloproteinase-7 tri ...... 2 in the extracellular matrix.
@en
type
label
Matrix metalloproteinase-7 tri ...... 2 in the extracellular matrix.
@en
prefLabel
Matrix metalloproteinase-7 tri ...... 2 in the extracellular matrix.
@en
P2093
P2860
P1433
P1476
Matrix metalloproteinase-7 tri ...... 2 in the extracellular matrix
@en
P2093
Atsushi Ochiai
Genichiro Ishii
Hiroyuki Maeda
Keiichi Yano
Michio Nakamura
Shin'ichi Miyamoto
Takahiro Hasebe
Tsutomu Chiba
Yasushi Endoh
Zhang Shi-Chuang
P2860
P304
P356
10.1111/J.1349-7006.2007.00448.X
P577
2007-03-14T00:00:00Z